NCT06319560 Hydroxychloroquine in Type 2 Diabetes During Pregnancy
| NCT ID | NCT06319560 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National University of Malaysia |
| Condition | Diabetes in Pregnancy |
| Study Type | INTERVENTIONAL |
| Enrollment | 56 participants |
| Start Date | 2024-03-24 |
| Primary Completion | 2026-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 56 participants in total. It began in 2024-03-24 with a primary completion date of 2026-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to compare the use of hydroxychloroquine as an adjunct to the current treatment of pregnant women with Type 2 diabetes mellitus. The main questions it aims to answer are: * Does hydroxychloroquine improve the pregnancy outcomes in women with type 2 diabetes during pregnancy? * Does hydroxychloroquine improve the inflammatory markers in women with type 2 diabetes during pregnancy? Participants will be randomised into the intervention and control group. The control group will be on standard treatment where as the intervention group will receive hydroxychloroquine as an adjunct of standard treatment
Eligibility Criteria
Inclusion Criteria: * Singleton * Pregnant women with a confirmed diagnosis of type 2 Diabetes Mellitus Exclusion Criteria: * autoimmune disease such as Systemic Lupus Erythematosus or rheumatic disease * chronic kidney disease * fetal anomaly * women on steroid therapy * diabetic retinopathy * known thalassaemia or thalassaemia carrier
Contact & Investigator
Rahana Abd Rahman
PRINCIPAL INVESTIGATOR
UKM
Frequently Asked Questions
Who can join the NCT06319560 clinical trial?
This trial is open to female participants only, aged 20 Years or older, up to 45 Years, studying Diabetes in Pregnancy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06319560 currently recruiting?
Yes, NCT06319560 is actively recruiting participants. Contact the research team at drrahana@ukm.edu.my for enrollment information.
Where is the NCT06319560 trial being conducted?
This trial is being conducted at Cheras, Malaysia.
Who is sponsoring the NCT06319560 clinical trial?
NCT06319560 is sponsored by National University of Malaysia. The principal investigator is Rahana Abd Rahman at UKM. The trial plans to enroll 56 participants.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.